CLINICAL_TRIALS
research
· 2026-02-06
Clinical Trial Update: DNV001 Injection in Patients With Hypercholesterolemia [Phase 2]
Summary
Phase 2 trial of DNV001 Injection for primary hypercholesterolemia is currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hangzhou Dinovate Biotech Co., Ltd | Conditions: Primary Hypercholesterolemia | Phase 2 | Status: NOT_YET_RECRUITING